NEW YORK (GenomeWeb) – Curetis said today that based on a performance evaluation for the newest version of its Unyvero ITI Implant and Tissue Infection Application Cartridge, it has marked the cartridge as conforming with previous CE-IVD Marking. The firms also plans to launch the new generation cartridge internationally in the third quarter of 2016.
Curetis Second Generation Implant, Tissue Infection Application Cartridge Conforms to CE-IVD Marking
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.